Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...
Recursion Pharmaceuticals is maintained at a "Hold" rating, pending further regulatory clarity and late-stage trial initiation for REC-4881 in FAP. Updated phase 1b/2 TUPELO data show REC-4881 ...
ZNetwork on MSN
Interviewing Chat GPT, Part Two
This is Part Two, of our interview with Chat-GPT 5.6. As with Part One, I did not ask GPT questions based on my own interests or, in many cases, not knowing what I thought the answers would or should ...
Recursive released Flint Oct. 21, 2026: a 40B MoE coding model with 2.5B active params, Apache 2.0, free on OpenRouter.
Recursion Pharma launches a $200M equity offering and reports a Sanofi milestone but is rated a Hold on limited near-term catalysts. Click for more on RXRX.
I was thinking about a program to solve Sudoku.You fill a 9x9 grid with numbers from 1 to 9. The same number must not be ...
TasteVal benchmark finds Claude Opus 5.5 outpaced 24 expert AI researchers on experiment design at 1/30 the per-attempt cost, ...
When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...
As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.
A new generalized single step method combines any number of hierarchical genomic datasets with pedigree, avoiding imputation ...
A simulation study shows a safety-constrained nonlinear model predictive controller can keep a virtual autonomous vehicle ...
Leveraging its strong technological moat in enterprise-grade AI Agents and AI4S, as well as its outstanding achievements in embedding AI into industrial upgrading, Fabarta has been officially invited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results